Physician
Le-Lindqwister, Nguyet
Le-Lindqwister, Nguyet was paid $275K by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is 96413, Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance — 41% of everything it billed.
33Billing provider infoLE-LINDQWISTER, NGUYET
PEORIA, IL 61615
PEORIA, IL 61615
33aNPI1174522486assigned 07/19/2005
33bProvider typeHematology & Oncology Physician
28Total paid$275K
24GClaims12,893
24DCodes billed17
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Illinois
Rank by total paid#8 of 285
Median peer was paid$31K
This provider vs. median8.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,282 | $22K | |
| 2019 | 2,430 | $34K | |
| 2020 | 2,147 | $40K | |
| 2021 | 2,228 | $57K | |
| 2022 | 1,500 | $43K | |
| 2023 | 1,916 | $45K | |
| 2024incomplete | 1,390 | $34K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 41% | 2,179 | 1,134 | $112K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 1,673 | 1,452 | $69K |
| 80053 | Comprehensive metabolic panel | 8.7% | 2,398 | 1,857 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.8% | 2,766 | 1,982 | $16K |
| 96367 | 5.3% | 949 | 489 | $15K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.8% | 550 | 524 | $13K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.9% | 552 | 296 | $8K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.9% | 309 | 218 | $8K |
| 86300 | 1.3% | 171 | 160 | $4K | |
| J1756 | Injection, iron sucrose, 1 mg | 1.0% | 69 | 44 | $3K |
| 96417 | <1% | 54 | 24 | $2K | |
| 83735 | <1% | 145 | 102 | $913.32 |
5 more codes
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 679 | $830.88 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 123 | $554.52 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 223 | $193.79 |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 12 | $158.28 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 41 | $30.09 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.